Diagnostics
News and analysis on diagnostic technologies and applications.
Esya Labs, Alamar Biosciences Partner on Biomarker Discovery Servicess
The companies will combine technologies to provide tailored assays for pharma firms developing therapies for neurological and inflammatory diseases.
The McGill University team is advancing a test, dubbed DOvEEgene, which sequences DNA from a uterine brush sample to detect cancer-associated mutations.
Cerebral Palsy Sequencing Study Finds Clinically Actionable Alterations
Researchers trawled exome sequencing data to identify clinically actionable variants in 8 percent of cerebral palsy patients tested.
Lucid Diagnostics Raises $22M in Convertible Debt Refinancing
The cash raised brings the company’s total holdings to about $33 million, enough to see it through plans to gain reimbursement for its esophageal cancer test.
Medicover Genetics Receives IVDR Certification for Genetic Testing Reagent Kit
The TarCET Kit offers a suite of sequencing panels covering a range of genetic conditions including metabolic disorders, infertility, and cardiovascular diseases.